Investment Case

As and International consumer self-care company, we create value for shareholders by developing, manufacturing and commercialising products for the self-care market.

We create value for shareholders by acquiring or developing, manufacturing and commercialising products/brands for the self-care market globally.

Venture Life is a business with multiple revenue growth opportunities, both organic and through an acquisition strategy. Our in-house manufacturing capability is a key differentiating factor from our peers.

What are our strategic objectives?

We create value for shareholders by acquiring or developing, manufacturing and commercialising products/brands for the self-care market globally.

Our business model

We have multiple revenue growth opportunities, both organically and through our acquisition strategy.

Our key activities Based on a vertically integrated approach, we either acquire or develop self-care products and brands. These products are then manufactured in-house and sold to a network of international partners as well as to key retailers and through online channels in the UK, The Netherlands and Italian markets.

Fully Integrated for growth

Our 5,500m2 facility is located in northern Italy, near Milan. This facility manufactures both our wholly owned Venture Life Brands and Customer Brands, which are sold under the customers’ brand names.

Our 2,600m2 Swedish facility is in Gnesta, south of Stockholm, and manufactures the bacterial vaginosis and moisture gel under our own brand of Balance Active, but also under customer brand names. It contains a state of the art fully automated filling line that can produce

270 long neck tubes per minute.

We have over 35 years of experience in developing consumer healthcare products (registered as Medical Devices or Cosmetics), and a strong technical team in place with regulatory expertise. This in-house ability to develop and manufacture allows us to be agile in responding to market demand.

Our development and manufacturing capability is a key revenue driver for the Group. With our strong growth to date and strategic ambition, we have invested significantly over the last couple of years to increase the manufacturing capacity.

Operational leverage

Operational leverage is a critical factor in driving revenue for our Group. Our continuous growth and strategic aspirations have led us to make substantial investments in expanding our manufacturing capacity in recent years.

Our state-of-the-art manufacturing and development facility possess ample potential for generating additional revenue. As of the end of 2022, it is estimated that we have a spare capacity of 55%. This facility caters to both VLG and Customer Brands, allowing us to maximize its utilization and revenue potential.

Financial performance

+34%Group Revenue in 2022
+36%Gross profit in 2022
+35]%Adjusted EBITDA in 2022

Distribution and our partners

Key to our growth is our continued drive to be the “partner of choice” for self-care products by fostering and nurturing strong partnerships all over the world, and providing the highest levels of service.

International

UK

Company presentation

For more detailed information please download our latest Company presentation: